DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

GSPCROP vs SUDARSHAN: Stock Comparison

GSP CROP SCIENCE vs SUDARSHAN PHARMA INDUpdated 13 Nov 26, 4:08 PM ISTNSE & company filings

GSP CROP SCIENCE shows a higher dividend yield and a higher net margin, while SUDARSHAN PHARMA IND shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

GSPCROP leads 6; SUDARSHAN leads 1 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

GSPCROPSUDARSHAN

Valuation lens

What price are you paying?

Market CapContext only
₹2,052 Cr
₹0 Cr
P/E RatioSUDARSHAN has the lower reading
31.66x
28.27x ✓
P/B RatioGSPCROP has the lower reading
2.46x ✓
4.11x
EPSGSPCROP has the higher reading
₹9.6 ✓
₹0.32
Book ValueContext only
₹165.59
₹6.14
Dividend YieldGSPCROP has the higher reading
0.23% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/E Ratio
SUDARSHAN has a lower P/E
28.27x vs 31.66x
P/B Ratio
GSPCROP has a lower P/B
2.46x vs 4.11x
EPS
GSPCROP has higher earnings per share
₹9.6 vs ₹0.32
Dividend Yield
GSPCROP has a higher dividend yield
0.23% vs 0%
Qtr Sales Growth
GSPCROP has stronger quarterly sales growth
44.67% vs 24.4%
Qtr Profit Growth
GSPCROP has stronger quarterly profit growth
69.11% vs 38.7%
Net Margin
GSPCROP has a higher net margin
6.24% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricGSPCROPSUDARSHAN
Live Price₹438.7₹32.71
Day Change0.65%0.03%
Volume2.95 L92,985
52-Week High₹667.95₹39.3
52-Week Low₹328₹31.01
Distance from 52W High-34.32%-16.77%

Valuation

MetricGSPCROPSUDARSHAN
Market Cap₹2,052 Cr₹0 Cr
P/E Ratio31.66x28.27x
P/B Ratio2.46x4.11x
EPS₹9.6₹0.32
Book Value₹165.59₹6.14
Dividend Yield0.23%0%

Growth

MetricGSPCROPSUDARSHAN
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth44.67%24.4%
Qtr Profit Growth69.11%38.7%

Profitability & Leverage

MetricGSPCROPSUDARSHAN
ROE12.23%—
ROCE14.32%—
Net Margin6.24%0%
Operating Margin9.4%—
Debt to Equity0.29x—

Shareholding

As of Sep 2026 • change vs previous quarter
MetricGSPCROPSUDARSHAN
Promoter Holding71.73%57.81%▼ 1.12 pp
FII Holding9.55%▲ 0.36 pp21.95%▲ 2.57 pp
DII Holding0%▼ 0.37 pp0%
Public Holding18.73%▲ 0.01 pp20.19%▼ 1.45 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GSP CROP SCIENCE and SUDARSHAN PHARMA IND.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.